WG
PRVA icon

Winton Group’s Privia Health PRVA Stock Holding History

Winton Group’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-56,618
Closed -$1.41M – 1081
2025
Q3 		$1.41M Buy
56,618
+172
+0.3% +$3.7K 0.05% 320
2025
Q2 		$1.3M Sell
56,446
-96
-0.2% -$2.22K 0.07% 344
2025
Q1 		$1.27M Sell
56,542
-4,065
-7% -$94.4K 0.08% 251
2024
Q4 		$1.18M Buy
60,607
+902
+2% +$17.9K 0.08% 235
2024
Q3 		$1.09M Buy
59,705
+4,784
+9% +$91.3K 0.08% 251
2024
Q2 		$955K Buy
54,921
+10,942
+25% +$194K 0.06% 268
2024
Q1 		$862K Buy
43,979
+25,340
+136% +$535K 0.06% 349
2023
Q4 		$429K Buy
18,639
+1,327
+8% +$29.7K 0.03% 395
2023
Q3 		$398K Buy
17,312
+2,222
+15% +$56.5K 0.03% 364
2023
Q2 		$394K Buy
+15,090
New +$399K 0.03% 422
2022
Q4 		– Sell
-9,626
Closed -$328K – 1016
2022
Q3 		$328K Buy
+9,626
New +$356K 0.02% 767

Other funds holding PRVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Winton Group's PRVA Position: Q4 2025 in Review

Winton Group sold out of Privia Health (PRVA) in Q4 2025, closing a stake of 56,618 shares — an estimated $1.41M sold.

Winton Group first reported a position in PRVA in Q3 2022 and held it in 11 quarters. The position peaked at $1.41M in Q3 2025. 276 funds tracked by Wall St. Rank hold PRVA as of Q4 2025.

  • Winton Group reported no remaining Privia Health position as of Q4 2025 after selling out during the quarter.
  • Winton Group sold 56,618 Privia Health shares in Q4 2025, an estimated $1.41M.
  • Winton Group first reported a position in Privia Health in Q3 2022 and held it in 11 quarters.
  • Winton Group's Privia Health position peaked at $1.41M in Q3 2025.
  • 276 funds tracked by Wall St. Rank held Privia Health as of Q4 2025.

Based on Winton Group's 13F filing for Q4 2025, filed 11 Feb 2026.